Logo Alignment Healthcare, Inc.

Alignment Healthcare, Inc. (ALHC) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Alignment Healthcare, Inc. · Health Care · ref. ETF XLV · 50 calls · price $8.3
🔔Price alertsCreate an alert →
What the company does: Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer.

📈 Alignment Healthcare, Inc. (ALHC) stock price

$8.3-51.9% over range
Oct 14, 25low $7.55 · high $24.56Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
57% recommend buying · 7 analysts
📊 JPI status : Alignment Healthcare, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 ALHC price target & analyst consensus — price $8.30

The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$19+128.9%
Median target · of 6 targets$11+32.5%
Lowest target · 1 firm of 6$9+8.4%
Current price$8.3
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 6100% $9 ↔ $19
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $9 (+8.4 %), call made on October 13, 2026, maturing on October 13, 2027 (1 d ago).

The 1 reliable analyst $9+8.4 %
The 5 other firms $12+45 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $9 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy457%
Hold343%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Alignment Healthcare, Inc.? The JPI assistant answers using our backtest data.

🏛️ Alignment Healthcare, Inc. insider buying: who's buying and how much › open the full page

1 insider bought1 buys / 6 mo $198k

🔎 Detailed analyses

✅ Historical analyst reliability on ALHC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Stifel ↗ 100% +81.1% 6
Stephens & Co. ↗ 100% +60.1% 3
Baird ↗ 100% +57.9% 3
TD Cowen ↗ 67% +21.6% 3
Piper Sandler ↗ 57% +9.4% 7
B of A Securities ↗ 50% -12.7% 2
Raymond James ↗ 38% -14.3% 8
Morgan Stanley ↗ 25% -15.3% 8
Goldman Sachs ↗ 0% -23.9% 6
Cowen & Co. 0% -32.6% 3
See the other 1 firms
Barclays ↗ 0% -57.0% 7

📊 What $1,000 invested in Alignment Healthcare, Inc. would be worth › open the full page

In short — $1,000 invested in Alignment Healthcare, Inc. 10 years ago would be worth $1,225 today, i.e. +4%/yr on average. Best year: 2025 (+73%), worst: 2023 (-27%). Price performance, excluding dividends.

If I'd invested $1,000 in Alignment Healthcare, Inc.

InvestmentWorth todayGain
1 years ago$1,812+81%
3 years ago$1,803+80%
5 years ago$1,225+22%
→ See Alignment Healthcare, Inc.'s full return history + gain calculator

Return by year (Alignment Healthcare, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+5%$1,048 (+5%)
2025+73%$1,812 (+81%)
2024+36%$2,462 (+146%)
→ See Alignment Healthcare, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Alignment Healthcare, Inc.

Loading news…

📋 All analyst calls on ALHC

UBS ↗
Oct 12, 26
■ Neutral neutral · not a buy · 🎯$9
Price at call : $8.3 — gap to target +8%
Today : $8.3 — gap to target +8%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Oct 12, 27
TD Cowen ↗
Oct 12, 26
▲ Buy · 🎯$12
Price at call : $8.3 — upside +45%
Today : $8.3 — upside +45%
🎯 on ALHC : 100% (2 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Oct 12, 27
William Blair ↗
Oct 9, 26
■ Market Perform neutral · not a buy
🎯 on ALHC : no call matured yet · 📊 on Health : 32% · -10.8% (25 calls)
in progress (365j)
matures : Oct 9, 27
JP Morgan ↗
Oct 9, 26
▲ Overweight · 🎯$10
Price at call : $8.09 — upside +24%
Today : $8.3 — upside +20%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Oct 9, 27
Keybanc ↗
Oct 9, 26
▲ Overweight · 🎯$12
Price at call : $7.55 — upside +59%
Today : $8.3 — upside +45%
🎯 on ALHC : 0% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Oct 9, 27
Barclays ↗
Oct 6, 26
■ Equal-Weight neutral · not a buy · 🎯$10
Price at call : $8.55 — gap to target +17%
Today : $8.3 — gap to target +20%
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 6, 27
JP Morgan ↗
Aug 4, 26
▲ Overweight · 🎯$22
Price at call : $13.68 — upside +61%
Today : $8.3 — upside +165%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Aug 4, 27
Raymond James ↗
Aug 3, 26
▲ Outperform · 🎯$19
Price at call : $13.52 — upside +41%
Today : $8.3 — upside +129%
🎯 on ALHC : no call matured yet · 📊 on Health : 39.7% · -2.1% (219 calls)
in progress (365j)
matures : Aug 3, 27
See the other 42 calls, newest to oldest
Barclays ↗
May 26, 26
■ Equal-Weight neutral · not a buy · 🎯$16
Price at call : $15.93 — gap to target +0%
Today : $8.3 — gap to target +93%
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 26, 27
UBS ↗
May 1, 26
■ Neutral neutral · not a buy · 🎯$22
Price at call : $19.26 — gap to target +14%
Today : $8.3 — gap to target +165%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 1, 27
Barclays ↗
May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $19.26 — gap to target -1%
Today : $8.3 — gap to target +129%
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : May 1, 27
JP Morgan ↗
Feb 5, 26
▲ Overweight · 🎯$26
Price at call : $21.75 — upside +20%
Today : $8.3 — upside +213%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Feb 5, 27
TD Cowen ↗
Jan 16, 26
▲ Buy · 🎯$25
Price at call : $22.74 — upside +10%
Today : $8.3 — upside +201%
🎯 on ALHC : 100% (2 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
in progress (365j)
matures : Jan 16, 27
UBS ↗
Jan 14, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $22.5 — gap to target -7%
Today : $8.3 — gap to target +153%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jan 14, 27
Piper Sandler ↗
Jan 6, 26
▲ Overweight · 🎯$30
Price at call : $20.93 — upside +43%
Today : $8.3 — upside +261%
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Jan 6, 27
JP Morgan ↗
Dec 17, 25
▲ Overweight · 🎯$23
Price at call : $20.41 — upside +13%
Today : $8.3 — upside +177%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Dec 17, 26
JP Morgan ↗
Nov 24, 25
▲ Overweight · 🎯$20
Price at call : $17.62 — upside +14%
Today : $8.3 — upside +141%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 24, 26
JP Morgan ↗
Nov 5, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $16.49 — gap to target +9%
Today : $8.3 — gap to target +117%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 5, 26
Barclays ↗
Nov 3, 25
■ Equal-Weight neutral · not a buy · 🎯$18
Price at call : $16.84 — gap to target +7%
Today : $8.3 — gap to target +117%
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Nov 3, 26
UBS ↗
Oct 31, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $16.84 — gap to target +7%
Today : $8.3 — gap to target +117%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Oct 31, 26
Goldman Sachs ↗
Oct 14, 25
▲ Buy · 🎯$21
Price at call : $17.26 — upside +22%
Today : $8.3 — upside +153%
🎯 on ALHC : no call matured yet · 📊 on Health : 51.9% · +5.8% (104 calls)
in progress (365j)
matures : Oct 14, 26
Keybanc ↗
Aug 25, 25
▲ Overweight · 🎯$21
Price at call : $15.58 — upside +35%
Today : $8.3 — upside +153%
Expected +35% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ALHC : 0% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
-12.8%
stock -13% · XLV +29%
matured Aug 25, 26
Barclays ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$13
Price at call : $12.97 — gap to target +0%
Today : $8.3 — gap to target +57%
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Aug 1, 26
UBS ↗
May 3, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $15.48 — gap to target +10%
Today : $8.3 — gap to target +105%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 3, 26
Baird ↗
Apr 15, 25
▲ Outperform · 🎯$22
Price at call : $19.43 — upside +13%
Today : $8.3 — upside +165%
Expected +13% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+7.7%
stock +8% · XLV +7%
matured Apr 15, 26
Stifel ↗
Apr 8, 25
▲ Buy · 🎯$23
Price at call : $18.54 — upside +24%
Today : $8.3 — upside +177%
Expected +24% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (5 calls matureds) · 📊 on Health : 44.3% · +6.0% (97 calls)
+15.3%
stock +15% · XLV +8%
matured Apr 8, 26
JP Morgan ↗
Mar 6, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $14.89 — gap to target +14%
Today : $8.3 — gap to target +105%
🎯 on ALHC : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Mar 6, 26
Piper Sandler ↗
Mar 4, 25
▲ Overweight · 🎯$21
Price at call : $15.81 — upside +33%
Today : $8.3 — upside +153%
Expected +33% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+17.5%
stock +17% · XLV +3%
matured Mar 4, 26
▲ Buy · 🎯$18.5
Price at call : $15.81 — upside +17%
Today : $8.3 — upside +123%
Expected +17% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
+17.5%
stock +17% · XLV +3%
matured Mar 4, 26
Stifel ↗
Feb 28, 25
▲ Buy · 🎯$18
Price at call : $15.52 — upside +16%
Today : $8.3 — upside +117%
Expected +16% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (5 calls matureds) · 📊 on Health : 44.3% · +6.0% (97 calls)
+26.6%
stock +27% · XLV +6%
matured Feb 28, 26
Barclays ↗
Feb 28, 25
▼ Underweight · 🎯$9
Price at call : $15.52 — upside -42%
Today : $8.3 — upside +8%
Expected -42% · Actual +27% · Reason (≤ −15%) : ✗ No
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-26.6%
stock +27% · XLV +6%
matured Feb 28, 26
Stephens & Co. ↗
Feb 24, 25
▲ Overweight · 🎯$17
Price at call : $13.39 — upside +27%
Today : $8.3 — upside +105%
Expected +27% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+50.3%
stock +50% · XLV +6%
matured Feb 24, 26
Stifel ↗
Jan 14, 25
▲ Buy · 🎯$16
Price at call : $13.51 — upside +18%
Today : $8.3 — upside +93%
Expected +18% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (5 calls matureds) · 📊 on Health : 44.3% · +6.0% (97 calls)
+61.0%
stock +61% · XLV +13%
matured Jan 14, 26
▲ Overweight · 🎯$17
Price at call : $11.56 — upside +47%
Today : $8.3 — upside +105%
Expected +47% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+74.9%
stock +75% · XLV +13%
matured Jan 2, 26
▲ Overweight · 🎯$17
Price at call : $12.52 — upside +36%
Today : $8.3 — upside +105%
Expected +36% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+54.9%
stock +55% · XLV +5%
matured Dec 3, 25
TD Cowen ↗
Oct 31, 24
▲ Buy · 🎯$13
Price at call : $12.95 — upside +0%
Today : $8.3 — upside +57%
Expected +0% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (2 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
+30.0%
stock +30% · XLV -2%
matured Oct 31, 25
Barclays ↗
Oct 30, 24
▼ Underweight · 🎯$8
Price at call : $12.4 — upside -35%
Today : $8.3 — upside -4%
Expected -35% · Actual +36% · Reason (≤ −15%) : ✗ No
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-36.0%
stock +36% · XLV -2%
matured Oct 30, 25
UBS ↗
Oct 30, 24
■ Neutral neutral · not a buy · 🎯$12
Price at call : $12.4 — gap to target -3%
Today : $8.3 — gap to target +45%
🎯 on ALHC : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Oct 30, 25
Keybanc ↗
Oct 11, 24
■ Sector Weight neutral · not a buy
🎯 on ALHC : 0% (1 call matured) · 📊 on Health : 23.6% · -18.3% (110 calls)
in progress (365j)
matures : Oct 11, 25
Baird ↗
Aug 14, 24
▲ Outperform · 🎯$11
Price at call : $8.67 — upside +27%
Today : $8.3 — upside +33%
Expected +27% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+70.9%
stock +71% · XLV -12%
matured Aug 14, 25
TD Cowen ↗
Aug 6, 24
▲ Buy · 🎯$10
Price at call : $8.75 — upside +14%
Today : $8.3 — upside +20%
Expected +14% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (2 calls matureds) · 📊 on Health : 50% · -1.0% (40 calls)
+58.4%
stock +58% · XLV -12%
matured Aug 6, 25
Piper Sandler ↗
Aug 6, 24
▲ Overweight · 🎯$10
Price at call : $9.17 — upside +9%
Today : $8.3 — upside +20%
Expected +9% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+49.5%
stock +50% · XLV -12%
matured Aug 6, 25
Barclays ↗
Aug 6, 24
▼ Underweight · 🎯$7
Price at call : $9.17 — upside -24%
Today : $8.3 — upside -16%
Expected -24% · Actual +50% · Reason (≤ −15%) : ✗ No
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-49.5%
stock +50% · XLV -12%
matured Aug 6, 25
Stifel ↗
Jul 26, 24
▲ Buy · 🎯$12
Price at call : $8.56 — upside +40%
Today : $8.3 — upside +45%
Expected +40% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (5 calls matureds) · 📊 on Health : 44.3% · +6.0% (97 calls)
+38.6%
stock +39% · XLV -10%
matured Jul 26, 25
Baird ↗
May 30, 24
▲ Outperform · 🎯$10
Price at call : $7.88 — upside +27%
Today : $8.3 — upside +20%
Expected +27% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 38.1% · -2.9% (84 calls)
+95.0%
stock +95% · XLV -6%
matured May 30, 25
Piper Sandler ↗
May 8, 24
▲ Overweight · 🎯$8
Price at call : $6.78 — upside +18%
Today : $8.3 — upside -4%
Expected +18% · Actual +127% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
+127.4%
stock +127% · XLV -6%
matured May 8, 25
■ Equal-Weight neutral · not a buy · 🎯$7
Price at call : $6.78 — gap to target +3%
Today : $8.3 — gap to target -16%
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
in progress (365j)
matures : May 3, 25
Stifel ↗
Apr 23, 24
▲ Buy · 🎯$9
Price at call : $5.18 — upside +74%
Today : $8.3 — upside +8%
Expected +74% · Actual +248% · Reason (≥ +15%) : ✓ Yes
🎯 on ALHC : 100% (5 calls matureds) · 📊 on Health : 44.3% · +6.0% (97 calls)
+248.3%
stock +248% · XLV -2%
matured Apr 23, 25
Piper Sandler ↗
Mar 6, 24
■ Neutral neutral · not a buy · 🎯$6
Price at call : $5.37 — gap to target +12%
Today : $8.3 — gap to target -28%
🎯 on ALHC : 100% (3 calls matureds) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Mar 6, 25
Barclays ↗
Mar 6, 24
▼ Underweight · 🎯$4.5
Price at call : $5.37 — upside -16%
Today : $8.3 — upside -46%
Expected -16% · Actual +184% · Reason (≤ −15%) : ✗ No
🎯 on ALHC : 0% (4 calls matureds) · 📊 on Health : 37% · -8.6% (154 calls)
-184.0%
stock +184% · XLV +2%
matured Mar 6, 25

Frequently asked questions

Should I buy Alignment Healthcare, Inc. stock?

This isn't buy advice. For Alignment Healthcare, Inc., the analyst consensus is "Buy", with an average price target of $11.00 (+33% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (6 calls tracked on Alignment Healthcare, Inc.). We show the numbers — you decide.

Is it too late to buy Alignment Healthcare, Inc.? How high can it go?

The most bullish analyst target on Alignment Healthcare, Inc. is $19.00 (+129% above today's price); the average is $11.00. That's the upside they see. Check how reliable those analysts have actually been on Alignment Healthcare, Inc. on our site before trusting it.

Is Alignment Healthcare, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Alignment Healthcare, Inc., the best hitting 100% over 6 calls. Current consensus: "Buy". Make your call on data, not noise.

Will Alignment Healthcare, Inc. stock recover (go back up)?

It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will ALHC stock recover (go back up)?

Should you invest in Alignment Healthcare, Inc.? The case for and against

The arguments for and against, one by one, from the numbers: why invest in ALHC (and why hesitate).

What has Alignment Healthcare, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: ALHC performance & returns.

Are insiders buying ALHC stock?

Executives' and large holders' buys and sells, decoded: insider buying on ALHC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)